Michael Thompson, MD
Hematology & Oncology Physician in Oak Ridge, Tennessee. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Michael Thompson, MD reported a CMS MIPS final score of 30/100 - below the 83.1 national average - and filed 1,049 Medicare Part D claims in 2023.
- 30/100
- MIPS score · -53 vs avg
- 1K
- Part D claims, 2023
- 74%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Thompson, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
30 3rd percentile higher than 3% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Thompson, MD sits
This provider among hematology & oncology physician peers
Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Thompson, MD writes more Part D claims than 64% of them and scores higher on MIPS quality than 1% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Michael Thompson, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Michael Thompson, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Thompson, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Tennessee
How Hematology & Oncology Physician compares to other specialties among Tennessee providers
Largest specialties in Tennessee (% of in-state providers)
Hematology & Oncology Physician ranks #73 among Tennessee's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Tennessee provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Michael Thompson, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 30/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) - 30/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Hematology & Oncology Physician US NPIs
30/100 MIPS final score - 53.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 0. Cost dim: 100.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Thompson, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 200 NEW YORK AVE, Oak Ridge, TN, 37830, with a listed phone of (865) 835-5400. NPI 1023016631 was issued on 07/08/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Thompson most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,049 prescription claims written by this provider, covering 216 Medicare beneficiaries and totaling roughly $3.0 million in drug spend, split 26% brand-name and 74% generic by claim count, with an opioid prescribing rate of 8.7%. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 30/100 for the 2023 performance year (Quality 0, Cost 100), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1023016631 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/08/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Michael Thompson, MD's current license status, disciplinary history, and board certifications with the Tennessee Board of Medical Examiners in Tennessee before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Michael Thompson, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Thompson, MD. Source: openpaymentsdata.cms.gov.
Total received
$74
Largest payer
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
26% brand-name claims vs 74% generic, on 1,049 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,619
- Total Day Supply
- 45,381
- Brand vs Generic
- 26% brand / 74% generic
- Brand Drug Cost
- $2.6M
- Generic Drug Cost
- $362K
- Opioid Claims
- 91 (8.7% rate)
- Antibiotic Claims
- 28
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.88
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 20, 65-74: 93, 75-84: 82, 85+: 21
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Thompson, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
190 claims
- Eliquis
Eliquis
94 claims
- Exemestane 39
Exemestane
39 claims
- Hydroxyurea 38
Hydroxyurea
38 claims
- Imbruvica 36
Imbruvica
36 claims
- Jakafi 36
Jakafi
36 claims
- Ondansetron Hcl 34
Ondansetron Hcl
34 claims
- Pantoprazole Sodium 26
Pantoprazole Sodium
26 claims
| Drug | Claims |
|---|---|
| Anastrozole | 190 |
| Eliquis Apixaban | 94 |
| Exemestane | 39 |
| Hydroxyurea | 38 |
| Imbruvica Ibrutinib | 36 |
| Jakafi Ruxolitinib Phosphate | 36 |
| Ondansetron Hcl | 34 |
| Pantoprazole Sodium | 26 |
| Prednisone | 22 |
| Tamoxifen Citrate | 22 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Michael Thompson, MD fits within the Hematology & Oncology Physician landscape nationally.
Michael Thompson, MD's 1,049 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Tennessee
Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as Thompson.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Tennessee medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Tennessee
Frequently Asked Questions
What is Michael Thompson, MD's specialty? ▼
How much does Michael Thompson, MD prescribe under Medicare Part D? ▼
What is Michael Thompson, MD's Medicare quality score? ▼
Where is Michael Thompson, MD located? ▼
What is Michael Thompson, MD's NPI number? ▼
Does Michael Thompson, MD prescribe more brand-name or generic drugs? ▼
Does Michael Thompson, MD prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Michael Thompson, MD prescribe most often? ▼
Does Michael Thompson, MD accept Medicare? ▼
How can I verify Michael Thompson, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology